Parkinson Disease: The Enteric Nervous System Spills its Guts

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neurology

• Publication date

  2012-02-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.0b013e31824bd195PMID 22371415
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease.

  2012cited by this paper
• Neurology and neurologic practice in China

  2011cited by this paper
• Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

  2010cited by this paper
• Launch of the health-care reform plan in China.

  2009cited by this paper
• Routine colonic biopsies as a new tool to study the enteric nervous system in living patients

  2009cited by this paper

• Physical exercise and inflammation in Parkinson’s disease: a review

  2025cites this paper
• Oxidative modification of methionine residue in α-synuclein by dopamine induces cellular vulnerability, oligomerization and secretion of α-synuclein

  2025cites this paper
• Gut-Brain Axis Modulation of Metabolic Disorders: Exploring the Intertwined Neurohumoral Pathways and Therapeutic Prospects

  2024cites this paper
• The Golgi complex of dopaminergic enteric neurons is fragmented in a hemiparkinsonian rat model

  2023cites this paper
• Plasma Metabolic Analysis Reveals the Dysregulation of Short-Chain Fatty Acid Metabolism in Parkinson’s Disease

  2023cites this paper
• Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson’s Disease from Mice to Human

  2023cites this paper
• Age-Dependent Aggregation of α-Synuclein in the Nervous System of Gut-Brain Axis is Associated with Caspase-1 Activation

  2022influential citation
• Role and Mechanism of Vitamin A Metabolism in the Pathophysiology of Parkinson’s Disease

  2021cites this paper
• Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient Cells

  2021cites this paper
• Age-dependent aggregation of α-synuclein in the nervous system of gut-brain axis is associated with caspase-1 activation

  2021cites this paper
• Enteric Glia at the Crossroads between Intestinal Immune System and Epithelial Barrier: Implications for Parkinson Disease

  2020cites this paper
• Potential of Probiotics for the Treatment of Parkinson’s Disease: A Systematic Review of Clinical studies

  2020cites this paper
• Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease.

  2020cites this paper
• Therapeutic innovation in Parkinson’s disease: a 2020 update on disease-modifying approaches

  2020cites this paper
• Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links

  2020cites this paper
• Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson disease

  2020cites this paper
• Tau accumulates in Crohn’s disease gut

  2020cites this paper
• Toxic protein spread in neurodegeneration: reality vs fantasy

  2020cites this paper
• A New Synuclein-Transgenic Mouse Model for Early Parkinson’s Reveals Molecular Features of Preclinical Disease

  2020cites this paper
• Risk of Parkinson’s disease after colectomy: longitudinal follow-up study using a national sample cohort

  2019cites this paper
• The Locus coeruleus in Parkinson’s disease - from basic research to new translational perspectives -

  2019cites this paper
• Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease

  2019cites this paper
• Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease Modeling

  2019cites this paper
• A neuroscience perspective of the gut theory of Parkinson's disease

  2019cites this paper
• “Photobiomics”: Can Light, Including Photobiomodulation, Alter the Microbiome?

  2019cites this paper
• Central Nervous System-Derived Exosomal Alpha-Synuclein in Serum May Be a Biomarker in Parkinson's Disease.

  2019cites this paper
• Analysis of the clinical features of early Parkinson’s disease with comparatively integrated intestinal function

  2018cites this paper
• Neuropathology of autonomic dysfunction in synucleinopathies

  2018cites this paper
• Age-dependent elevations of oligomeric and phosphorylated alpha-synuclein synchronously occurs in the brain and gastrointestinal tract of cynomolgus monkeys.

  2018cites this paper
• The enteric nervous system in PD: gateway, bystander victim, or source of solutions

  2018cites this paper
• Crohn’s and Parkinson disease: is LRRK2 lurking around the corner?

  2018cites this paper
• Role of Microbiota in Neurodegenerative Diseases

  2018cites this paper
• Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies

  2018cites this paper
• The Dynamic Response of Enteric Neurons to Polymeric Substrates

  2018cites this paper
• Translational Glycobiology The N -glycosylation of immunoglobulin G as a novel biomarker of Parkinson ’ s disease

  2017cites this paper
• Outlier based literature exploration for cross-domain linking of Alzheimer's disease and gut microbiota

  2017cites this paper
• Live calcium and mitochondrial imaging in the enteric nervous system of Parkinson patients and controls

  2017cites this paper
• The Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists

  2017cites this paper
• Neuropathology of Nonmotor Symptoms of Parkinson's Disease.

  2017cites this paper
• A practical review of gastrointestinal manifestations in Parkinson's disease.

  2017cites this paper
• LRRK2 Expression in the Enteric Nervous System: ENSuring Its Significance

  2017cites this paper
• The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease

  2017influential citation
• Colonic diverticular disease: A new risk factor for Parkinson's disease?

  2017cites this paper
• Reducing the Search Space in Literature-Based Discovery by Exploring Outlier Documents: a Case Study in Finding Links Between Gut Microbiome and Alzheimer’s Disease

  2017cites this paper
• Problémamegoldó ápolási-gondozási modell Parkinson-kórban

  2016cites this paper
• Gastrointestinal dysfunction in idiopathic Parkinsonism: A narrative review

  2016cites this paper
• Cross‐linking for the analysis of α‐synuclein in the enteric nervous system

  2016cites this paper
• Phenotype and distribution pattern of nestin-GFP-expressing cells in murine myenteric plexus

  2016cites this paper
• α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects

  2016cites this paper
• Alpha‐synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker

  2016influential citation
• Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies

  2016cites this paper
• Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments

  2016cites this paper
• Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells

  2016cites this paper
• Microbiome to Brain: Unravelling the Multidirectional Axes of Communication.

  2016cites this paper
• Microbial Endocrinology: Interkingdom Signaling in Infectious Disease and Health

  2016cites this paper
• Vagal neurocircuitry and its influence on gastric motility

  2016cites this paper
• A rapid and efficient method for dissociated cultures of mouse myenteric neurons.

  2016cites this paper
• In vivo gastric detection of α‐synuclein inclusions in Parkinson's disease

  2015cites this paper
• Optimizing Western Blots for the Detection of Endogenous α-Synuclein in the Enteric Nervous System

  2015cites this paper
• Effects of Endurance Exercise Training on The Motor and Non-Motor Features of Parkinson's Disease: A Review

  2015cites this paper
• Clinical and pathological features of Parkinson's disease.

  2015cites this paper
• Colonic bacterial composition in Parkinson's disease

  2015cites this paper
• Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease

  2015cites this paper
• Structural alterations of the intestinal epithelial barrier in Parkinson’s disease

  2015cites this paper
• Isolation of high-purity myenteric plexus from adult human and mouse gastrointestinal tract

  2015cites this paper
• Gastrointestinal Autonomic Dysfunction in Patients with Parkinson’s Disease

  2015cites this paper
• Enteric glial cells: New players in Parkinson's disease?

  2015cites this paper
• Gastrointestinal Dysfunctions in Parkinson's Disease

  2015cites this paper
• Gastroparesis symptoms in Parkinson's disease :correlation with motor and non-motor symptoms and exploration of a novel drug to improve gastric emptying

  2015influential citation
• Der Gastrointestinaltrakt rückt ins Zentrum

  2015cites this paper
• La définition de la maladie de Parkinson est-elle clinique ?

  2014cites this paper
• The Gastrointestinal Tract Microbiome and Potential Link to Alzheimer’s Disease

  2014cites this paper
• Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System

  2014cites this paper
• Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis.

  2014cites this paper
• Delayed gastric emptying in Parkinson's disease

  2014influential citation
• Appraisal of the Dopaminergic and Noradrenergic Innervation of the Submucosal Plexus in PD

  2014cites this paper
• Targeted Discovery and Validation of Plasma Biomarkers of Parkinson’s Disease

  2014cites this paper
• Intravenous AAV9 efficiently transduces myenteric neurons in neonate and juvenile mice

  2014cites this paper
• Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease

  2014cites this paper
• Causes and Consequences of Degeneration of the Dorsal Motor Nucleus of the Vagus Nerve in Parkinson's Disease

  2014cites this paper
• Autonomic disorders predicting Parkinson's disease.

  2014cites this paper
• Enteric GFAP expression and phosphorylation in Parkinson's disease

  2014cites this paper
• GFAP variants in health and disease: stars of the brain… and gut

  2014cites this paper
• Nutrition and Gastrointestinal Health as Modulators of Parkinson’s Disease

  2014cites this paper
• The pathomechanisms underlying Parkinson's disease

  2014cites this paper
• Pharma-Nutrition

  2014cites this paper
• Macrophages are unsuccessful in clearing aggregated alpha‐synuclein from the gastrointestinal tract of healthy aged Fischer 344 rats

  2013cites this paper
• Effects of oral administration of rotenone on gastrointestinal functions in mice

  2013cites this paper
• Alpha‐synuclein expression patterns in the colonic submucosal plexus of the aging Fischer 344 rat: implications for biopsies in aging and neurodegenerative disorders?

  2013cites this paper
• Neuropathologie van de Ziekte van Parkinson De progressie van Lewy inclusies vanaf de nervus vagus tot aan de cerebrale cortex

  2013cites this paper
• REM sleep behaviour disorder: a marker of synucleinopathy

  2013cites this paper
• Le système nerveux entérique : une fenêtre sur l’atteinte du système nerveux central dans la maladie de Parkinson

  2013cites this paper
• AS ALTERAÇÕES GASTROINTESTINAIS E OLFATÓRIAS PRECEDEM OS SINAIS MOTORES NO MODELO EXPERIMENTAL DA DOENÇA DE PARKINSON INDUZIDO PELA ROTENONA

  2013cites this paper
• Dopamine-Mediated Oxidation of Methionine 127 in α-Synuclein Causes Cytotoxicity and Oligomerization of α-Synuclein

  2013cites this paper
• REM sleep behaviour disorder: a marker of synucleinopathy.

  2013cites this paper
• Cognitive dysfunction and depression in Parkinson’s disease: what can be learned from rodent models?

  2012cites this paper
• Gastroenterologische Probleme bei Parkinson-Syndromen

  2012cites this paper
• Sekundäre Form der Obstipation aufgrund von medikamentösen Nebenwirkungen und endokrinen, neurologischen und psychiatrischen Erkrankungen – medikamentös-konservative Therapieoptionen

  2012cites this paper
• Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease

  2012cites this paper
• Analysis of colonic alpha-synuclein pathology in multiple system atrophy.

  2012cites this paper